Tuesday, March 8, 2016

(LML) INFOLEP's monthly Choice list - February 2016

Leprosy Mailing List – March 8,  2016

Ref.: (LML) INFOLEP’s monthly Choice list - February 2016

From:  Jiske Erlings, Amsterdam, the Netherlands


Dear Pieter, 

 

Greetings from Infolep!

Below you will find a selection of recent publications on leprosy and related subjects. Feel free to contact me to receive the full text versions if a link to the full text is not included.

On International Women’s Day you might want to check out our Leprosy & Gender collection: http://www.leprosy-information.org/category/subject/gender.

Keep sending us your publications on leprosy or material on leprosy in your language to include in the portal.


With kind regards,

Jiske Erlings

INFOLEP Information specialist

Follow Infolep on Facebook or Twitter

To subscribe/unsubscribe to this service, please send an email to: infolep@leprastichting.nl


Some NTD publications


de Vlas SJ, Stolk WA, le Rutte EA, Hontelez JA, Bakker R, Blok DJ, Cai R, Houweling TA, Kulik MC, Lenk EJ, Luyendijk M, Matthijsse SM, Redekop WK, Wagenaar I, Jacobson J, Nagelkerke NJ, Richardus JH.
Concerted Efforts to Control or Eliminate Neglected Tropical Diseases: How Much Health Will Be Gained? in: PLoS Negl Trop Dis. 2016 Feb 18;10(2):e0004386. Full text: http://www.leprosy-information.org/resource/concerted-efforts-control-or-eliminate-neglected-tropical-diseases-how-much-health-will-be

Hotez PJ, Pecoul B, Rijal S, Boehme C, Aksoy S, et al. (2016) Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies. in: PLoS Negl Trop Dis 10(3): e0003895. Full text online: http://www.leprosy-information.org/resource/eliminating-neglected-tropical-diseases-translational-science-and-new-technologies

Neglected Tropical Disease NGDO Network: Reflections on accomplishments in the prevention, treatment and management of consequences of NTDs - Special NNN2016 issue of Int. Health (2016) 8 Full text online: http://inthealth.oxfordjournals.org/content/8/suppl_1.toc

Combating NTDs: Lessons from India. PLOST NTDs Collection: http://collections.plos.org/india?#_=_


New Leprosy publications

Andrade PR, Jardim MR, da Silva AC, Manhaes PS, Antunes SL, Vital R, Prata RB, Petito RB, Pinheiro RO, Sarno EN. Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis. in: J Neuropathol Exp Neurol. 2016 Feb 17. Full text online: http://www.leprosy-information.org/resource/inflammatory-cytokines-are-involved-focal-demyelination-leprosy-neuritis

de Sousa JR, de Sousa RP, de Souza Aarão TL, Dias LB Jr, Carneiro FR, Fuzii HT, Quaresma JA. In situ expression of M2 macrophage subpopulation in leprosy skin lesions. in: Acta Trop. 2016 Jan 28. Abstract: http://leprosy-information.org/resource/situ-expression-m2-macrophage-subpopulation-leprosy-skin-lesions

De Matos HJ, Blok DJ, De Vlas SJ, Richardus JH. Leprosy New Case Detection Trends and the Future Effect of Preventive Interventions in Pará State, Brazil: A Modelling Study. in: PLoS Negl Trop Dis. 2016  10(3): e0004507. Full text online: http://www.leprosy-information.org/resource/leprosy-new-case-detection-trends-and-future-effect-preventive-interventions-par-state

Dimri D, Gupta A, Singh AK. Leprosy Continues to Occur in Hilly Areas of North India. in: Dermatol Res Pract. 2016;2016:7153876. Full text online: http://www.leprosy-information.org/resource/leprosy-continues-occur-hilly-areas-north-india

Fava VM, Manry J, Cobat A, Orlova M, Van Thuc N, Ba NN, Thai VH, Abel L, Alcaïs A, Schurr E; Canadian Lrrk2 in Inflammation Team (CLINT). A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy. in: PLoS Negl Trop Dis. 2016 Feb 4;10(2):e0004412. Full text online: http://www.leprosy-information.org/resource/missense-lrrk2-variant-risk-factor-excessive-inflammatory-responses-leprosy

Ganesan V, Mandal J. Primary oral tuberculosis in a patient with lepromatous leprosy: Diagnostic dilemma. in: Int J Mycobacteriol. 2016 Mar;5(1):102-5. Abstract: http://www.leprosy-information.org/resource/primary-oral-tuberculosis-patient-lepromatous-leprosy-diagnostic-dilemma

Júnior IA, Gresta LT, Noviello ML, Cartelle CT, Lyon S, Arantes RM. Leprosy classification methods: a comparative study in a referral center in Brazil.
in: Int J Infect Dis. 2016 Feb 26. ull text online: http://www.leprosy-information.org/resource/leprosy-classification-methods-comparative-study-referral-center-brazil

Lambert SM, Nigusse SD, Alembo DT, Walker SL, Nicholls PG, Idriss MH, Yamuah LK, Lockwood DN. Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia. in: PLoS Negl Trop Dis. 2016 Feb 6;10(2): e0004149. Full text online: http://www.leprosy-information.org/resource/comparison-efficacy-and-safety-ciclosporin-prednisolone-treatment-erythema-nodosum-leprosum

Mayboroda OA, van Hooij A, Derks R, van den Eeden SJ, Dijkman K, Khadge S, Thapa P, Kunwar CB, Hagge DA, Geluk A. Exploratory Urinary Metabolomics of Type 1 Leprosy Reactions. in: Int J Infect Dis. 2016 Feb 25. Full text online: http://www.leprosy-information.org/resource/exploratory-urinary-metabolomics-type-1-leprosy-reactions

Mendonça JA, Provenza JR, Castro de Mattos A, Ota FS, Appenzeller S. Hansen's disease: Descriptions of novel ultrasonographic findings. in: Joint Bone Spine. 2016 Jan 27. Abstract: http://www.leprosy-information.org/resource/hansens-disease-descriptions-novel-ultrasonographic-findings

Neela VS, Devalraju KP, Pydi SS, Sunder SR, Adiraju KR, Singh SS, Mpjs A, Valluri VL. Mycobacterial r32-kDa Ag specific T cell responses correlate with successful treatment and heightened antimicrobial response in human leprosy patients. in: Int Immunol. 2016 Feb 26. pii: dxw009. Abstract: http://www.leprosy-information.org/resource/mycobacterial-r32-kda-ag-specific-t-cell-responses-correlate-successful-treatment-and


Oliveira JM, Rêgo JL, de Lima Santana N, Braz M, Jamieson SE, Vieira TS, Magalhães TL, Machado PR, Blackwell JM, Castellucci LC. The -308bp TNF gene polymorphism influences tumor necrosis factor expression in leprosy patients in Bahia State, Brazil.
in: Infect Genet Evol. 2016 Jan 29. Abstract: http://leprosy-information.org/resource/308bp-tnf-gene-polymorphism-influences-tumor-necrosis-factor-expression-leprosy-patients

Pradeep Nair S, Vidyadharan S. A study of the prevalence of smear-positive leprosy cases in a tertiary care center in the post-elimination phase of leprosy. in: Int J Dermatol. 2016 Feb 12. Abstract: http://www.leprosy-information.org/resource/study-prevalence-smear-positive-leprosy-cases-tertiary-care-center-post-elimination-phase

Ramos JM, Romero D, Belinchón I. Epidemiology of Leprosy in Spain: The Role of the International Migration. Plos Negl Trop Dis 10(3): e0004321. in: Full text online: http://www.leprosy-information.org/resource/epidemiology-leprosy-spain-role-international-migration

Roset Bahmanyar E, Smith WC, Brennan P, Cummings R, Duthie M, Richardus JH, Saunderson P, Shwe T, Rosen S, Geluk A. Leprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User's Perspective.
in: PLoS Negl Trop Dis. 2016 Feb 11;10(2):e0004331. Full text online: http://www.leprosy-information.org/resource/leprosy-diagnostic-test-development-prerequisite-towards-elimination-requirements-users

Sen D, Satija L, Chatterji S, Majumder A, Gupta A, Kumar A. Ultrasonography and magnetic resonance imaging of ulnar nerve abscess in leprosy. in: Med J Armed Forces India. 2016 Jan;72(1):78-81. Abstract: http://www.leprosy-information.org/resource/ultrasonography-and-magnetic-resonance-imaging-ulnar-nerve-abscess-leprosy

Sharma I, Singh A, Mishra AK, Singh LC, Ramesh V, Saxena S. Is CXCL10/CXCR3 axis overexpression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase? in: Indian J Med Res. 2015 Dec;142(6):681-9. Full text online: http://leprosy-information.org/resource/cxcl10cxcr3-axis-overexpression-better-indicator-leprosy-type-1-reaction-inducible-nitric

Thomas M. A new era of diagnostic modalities for type 1 leprosy reactions: Promise for the future. in: Indian J Med Res. 2015 Dec;142(6):644-6. Full text online: http://leprosy-information.org/resource/new-era-diagnostic-modalities-type-1-leprosy-reactions-promise-future

Vieira AP, Trindade MÂ, Pagliari C, Avancini J, Sakai-Valente NY, Duarte AJ, Benard G. Development of Type 2, But Not Type 1, Leprosy Reactions is Associated with a Severe Reduction of Circulating and In situ Regulatory T-Cells. Am J Trop Med Hyg. 2016 Feb 22. Abstract: http://www.leprosy-information.org/resource/development-type-2-not-type-1-leprosy-reactions-associated-severe-reduction-circulating-and


Journals  & Newsletters

Community Eye Health: http://www.cehjournal.org/wp-content/uploads/Working-with-communities-to-improve-their-eye-health.pdf

Disability, CBR & Inclusive Development: http://dcidj.org/

Leprosy Review: http://www.lepra.org.uk/Pages/FAQs/Category/volume-85

Plos Neglegted Tropical Diseases: http://journals.plos.org/plosntds/

Revista de Leprología: http://www.leprosy-information.org/resource/revista-de-leprologia

WHO Goodwill Ambassador’s Newsletter for the elimination of leprosy: http://www.leprosy-information.org/resource/who-goodwill-ambassador-s-newsletter-elimination-leprosy


Other Information Sources


You might also be interested in The Leprosy Mailing List (LML), a free moderated email list that allows all persons interested in this theme to share ideas, information, experiences and questions. http://leprosymailinglist.blogspot.nl/

The new International Leprosy Association – History of Leprosy http://leprosyhistory.org/ website.

 
Jiske Erlings

Medewerker InfoLep / Information Officer

Infolep Leprosy Information Services

Postbus / P.O. Box 95005

1090 HA Amsterdam

The Netherlands

Tel:

+31 20 5950530

Mob:

-

Email:

J.Erlings@Leprastichting.NL

Web:

www.leprosy-information.org


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 


Dit e-mailbericht is verzonden vanaf een virusvrije computer die wordt beschermd door Avast.
www.avast.com

No comments: